Lung Cancer Non-small Cell Stage IV
Oncology
Prevalence
75.0 / 100K
Incidence
47.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Lung Cancer Non-small Cell Stage IV?
There are 1 clinical trial targeting Lung Cancer Non-small Cell Stage IV tracked by BioSniper.
What is the prevalence of Lung Cancer Non-small Cell Stage IV?
The estimated prevalence of Lung Cancer Non-small Cell Stage IV is approximately 75.0 per 100,000 population.
Deep-dive into Lung Cancer Non-small Cell Stage IV
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis